Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Biotech Industry Analysis

UpdatedJun 06, 2026
DataAggregated Company Financials
Companies5
  • 7D-5.4%
  • 3M-1.7%
  • 1Y-1.5%
  • YTD-21.1%

Over the last 7 days, the Biotech industry has dropped 5.1%, driven by Genmab declining 6.8%. As for the longer term, the industry's performance has been flat for the past year. In the next few years earnings are forecast to be pretty stable.

Industry Valuation and Performance

Has the Danish Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 06 Jun 2026DKK 134.8bDKK 40.5bDKK 12.8b11.9x10.5x3.3x
Mon, 04 May 2026DKK 140.9bDKK 39.2bDKK 13.9b10.5x10.1x3.6x
Wed, 01 Apr 2026DKK 141.4bDKK 39.5bDKK 14.0b10.9x10.1x3.6x
Fri, 27 Feb 2026DKK 154.1bDKK 39.7bDKK 14.9b6.2x10.3x3.9x
Sun, 25 Jan 2026DKK 177.3bDKK 40.4bDKK 18.9b6.3x9.4x4.4x
Tue, 23 Dec 2025DKK 176.8bDKK 40.5bDKK 19.0b6.1x9.3x4.4x
Thu, 20 Nov 2025DKK 172.6bDKK 41.0bDKK 19.1b5.9x9x4.2x
Sat, 18 Oct 2025DKK 180.0bDKK 38.9bDKK 16.8b13.1x10.7x4.6x
Mon, 15 Sep 2025DKK 158.8bDKK 38.8bDKK 16.7b12.7x9.5x4.1x
Wed, 13 Aug 2025DKK 128.6bDKK 29.6bDKK 8.8b11.9x14.6x4.3x
Fri, 11 Jul 2025DKK 127.6bDKK 26.9bDKK 7.3b11.3x17.4x4.7x
Sun, 08 Jun 2025DKK 137.5bDKK 27.5bDKK 7.5b11.3x18.3x5x
Tue, 06 May 2025DKK 136.3bDKK 27.3bDKK 7.7b11.9x17.7x5x
Thu, 03 Apr 2025DKK 126.3bDKK 27.3bDKK 7.7b11.1x16.4x4.6x
Sat, 01 Mar 2025DKK 165.7bDKK 27.7bDKK 7.8b12.4x21.2x6x
Mon, 27 Jan 2025DKK 166.7bDKK 26.0bDKK 4.7b17.1x35.5x6.4x
Wed, 25 Dec 2024DKK 160.6bDKK 26.0bDKK 4.7b16.6x34.2x6.2x
Fri, 22 Nov 2024DKK 157.0bDKK 26.0bDKK 4.7b16.5x33.4x6x
Sun, 20 Oct 2024DKK 174.2bDKK 25.5bDKK 5.5b21x31.8x6.8x
Tue, 17 Sep 2024DKK 198.1bDKK 25.5bDKK 5.5b24x36.2x7.8x
Thu, 15 Aug 2024DKK 198.2bDKK 26.0bDKK 5.7b19.2x34.7x7.6x
Sat, 13 Jul 2024DKK 197.3bDKK 24.8bDKK 5.6b17.7x35x8x
Mon, 10 Jun 2024DKK 179.2bDKK 24.8bDKK 5.6b18.5x31.8x7.2x
Wed, 08 May 2024DKK 184.3bDKK 25.2bDKK 6.2b16.2x29.9x7.3x
Fri, 05 Apr 2024DKK 188.4bDKK 23.9bDKK 5.0b19.7x37.4x7.9x
Sun, 03 Mar 2024DKK 184.8bDKK 22.8bDKK 4.3b23.5x43.2x8.1x
Tue, 30 Jan 2024DKK 168.1bDKK 23.3bDKK 4.2b23x40.4x7.2x
Thu, 28 Dec 2023DKK 176.2bDKK 23.3bDKK 4.2b25.9x42.3x7.6x
Sat, 25 Nov 2023DKK 172.7bDKK 23.3bDKK 4.2b25x41.5x7.4x
Mon, 23 Oct 2023DKK 162.9bDKK 22.0bDKK 4.7b18.9x34.4x7.4x
Wed, 20 Sep 2023DKK 199.5bDKK 22.0bDKK 4.7b23.4x42.1x9.1x
Fri, 18 Aug 2023DKK 188.2bDKK 20.6bDKK 3.9b35.9x48.6x9.1x
Sun, 16 Jul 2023DKK 200.5bDKK 19.5bDKK 4.4b40.9x45.5x10.3x
Tue, 13 Jun 2023DKK 209.4bDKK 19.5bDKK 4.4b44.7x47.5x10.7x
Price to Earnings Ratio

47.5x


Total Market Cap: DKK 209.4bTotal Earnings: DKK 4.4bTotal Revenue: DKK 19.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Biotech Industry Price to Earnings3Y Average 27x202420252026
Current Industry PE
  • Investors are pessimistic on the Danish Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 10.6x which is lower than its 3-year average PE of 27.0x.
  • The 3-year average PS ratio of 6.3x is higher than the industry's current PS ratio of 3.3x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have grown 43% per year over the last three years.
  • Revenues for these companies have grown 27% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare industry?

DK Market-1.52%
Healthcare-2.88%
Biotech-5.40%
Biotech-5.40%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ZEAL Zealand PharmaDKK 326.300.4%
+DKK 98.3m		-31.5%PE3.6x

Latest News

ZEAL
DKK 326.30
Zealand Pharma
7D
0.4%
1Y
-31.5%
BAVA
DKK 182.60
Bavarian Nordic
7D
-2.6%
1Y
0.9%
Narrative Update • Jun 01

BAVA: Public Preparedness Contracts And Vaccine Manufacturing Expansion Will Support 2026 Upside

Analysts have nudged their fair value estimate for Bavarian Nordic higher from DKK 268.33 to DKK 273.33. They point to adjusted assumptions around revenue growth, profit margins and future P/E as the main drivers of the updated price target.
GMAB
DKK 1,583.50
Genmab
7D
-7.1%
1Y
9.5%
BIOPOR
DKK 1.30
BioPorto
7D
-3.4%
1Y
-6.0%
STRAP
DKK 580.00
Strategic Partners
7D
-2.5%
1Y
-42.9%